Product logins

Find logins to all Clarivate products below.


Renal Anemia in Chronic Kidney Disease Non-Dialysis | Chart Trends | China | 2014

Through an in-depth review of patient charts, details such as product dosing and titration, switching, concomitant medications and a host of laboratory and patient demographic variables help define patient types and identify therapy triggers.
The attitudinal survey component allows for a better understanding of the rationale for treatment decisions and gaps between intended and actual treatment. By comparing what nephrologists report about patient care dynamics to actual treatment records, gaps in intended care versus actual care are uncovered and patient segments become more clearly defined.

Related Market Assessment Reports

Report
Chronic Kidney Disease – Landscape & Forecast – Disease Landscape & Forecast (G7)
Chronic kidney disease (CKD) encompasses a set of heterogeneous disorders that gradually damage the kidneys’ structure or function. To manage CKD and delay its progression to end-stage kidney…
Report
Psoriasis – Geographic Focus: China – Psoriasis | China In-Depth | China | 2025
Psoriasis is a chronic dermatologic condition with rising prevalence in China, particularly in urban areas where heightened awareness and improved access to care have led to higher diagnosis rates…
Report
Type 2 Diabetes – Geographic Focus: China – Type 2 Diabetes – China In-Depth (China)
In China, type 2 diabetes (T2D) continues to be a leading public health concern, with the highest global prevalence. Biguanides continue to dominate the market, but the use of SGLT-2 inhibitors and…
Report
Chronic Kidney Disease – Geographic Focus: China – Chronic Kidney Disease – China In-Depth (China)
Chronic kidney disease (CKD) is an irreversible condition requiring lifelong management. In China, CKD is notably widespread, particularly among older adults and those with chronic risk factors…
Report
Hepatocellular Carcinoma – Geographic Focus: China – Hepatocellular Carcinoma – China In-Depth (China)
The hepatocellular carcinoma therapy market in China is poised to experience significant growth, driven by an aging population and the high prevalence of hepatitis B and C infection. Angiogenesis…